PDPN overexpression has also been noted in inflammatory diseases, tissue damage and a wide range of cancers, and is directly correlated with disease outcomes, but the downstream signalling pathways and mechanisms of action of PDPN are still not fully understood. This evidence concerns the gene PDPN and cancer.